Abstract:Background: Efficacy of intravenous mesenchymal stem cells (MSCs) administration for myocardial infarction (MI) is limited by low cell migration to the damaged myocardium. Our previous study demostrated that migration ability of MSCs enhanced by hypoxia preconditioning (HPC). miRNA microarray displayed that miR-211 exhibited most significant change between HPC and normoxia cultured MSCs. The aim of this study is to study whether and how miR-211 regulate MSCs migration. Methods: In vitro, transwell assay were used to assess the migration ability of MSC moduated by miR-211 using overexpressing and knockdown lentivirus. The target gene of miR-211 predicted by Targetscan were verified by PCR, western blot and lucifurase assay. Chromatin immunoprecitation (ChiP) were used to explore the transcription factors that regulate the expression of miR-211. To evaluate the effect of miR-211 on MSCs migration in vivo, miR-211-mimic and miR-211-shRNA male MSCs were intravenously delivered 24h after MI, the engraft cells were detected by RT-PCR of SRY gene. Results: Quatitative RT-PCR showed that miR-211 expression of MSCs upregulated by HPC. MiR-211 mimic improved MSCs migration by 31.03% (p<0.05), however, knockdown miR-211 using shRNA attenuated MSCs migration ability significantly. Signal transducer and activator of transcription 5A (STAT5A) was predicted as one of miR-211 target genes, PCR and Western blot showed miR-211 overexpression dramatically decreased STAT5A expression, while miR-211 knockdown upregulated STAT5A. The luciferase assay showed the similar results. Transwell assay showed that STAT5A knockdown reverse the inhibition of MSCs migration induced by miR-211-shRNA. Intrestingly, ChiP assay showed that STAT5A can combine to the promoter of miR-211, which lead to the regulation of miR-211 transcription. In vivo data showed that MiR-211 overexpression enhanced MSCs homing to ischemic myocardium, and miR-211 overexprssing MSCs improved cardiac function 28days post-MI. However, miR-211 knockdown decreased MSCs homing and hampered cardiac function recovery. Conclusions: These results indicate that miR-211 has important role in regulating MSCs migration through targeting STAT5A, meanwhile STAT5A regulated miR-211 transcription.

Migration Of Human Mesenchymal Stem Cells Is Stimulated By Low Shear Stress Via Mapk Signaling

Mesenchymal Stem Cell Migration and Tissue Repair

Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy

BONE MARROW MESENCHYMAL STEM CELL MIGRATION DEPENDS IN PART ON KV21 CHANNEL ACTIVITY

MiR-211/STAT5A Signaling Modulates Migration of Mesenchymal Stem Cells to Improve Its Therapeutic Efficacy

Abstract 249: Mir-211 Regulates Bone Marrow Mesenchymal Stem Cells Migration Through Stat5a

Early Homing Behavior of Stro-1− Mesenchyme-Like Cells Derived from Human Embryonic Stem Cells in an Immunocompetent Xenogeneic Animal Model

Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury

Mesenchymal stem cells homing to improve bone healing

Recent Progress in Engineering Mesenchymal Stem Cell Differentiation

Future Orientation, School Contexts, and Problem Behaviors: A Multilevel Study

Mesenchymal Stem Cells for Regenerative Medicine

miR-29a-3p orchestrates key signaling pathways for enhanced migration of human mesenchymal stem cells

Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications

Stromal cell-derived factor-1-directed bone marrow mesenchymal stem cell migration in response to inflammatory and/or hypoxic stimuli

Mesenchymal Stem Cells: a Promising Candidate in Regenerative Medicine.

The effect of native and sonicated double-stranded polyribonucleotides on the course of spontaneous autoimmune disease in NZB and NZB/Swiss F1 mice.

A review of mesenchymal stem cells behavior regulated by physical cues

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

Identifying the Therapeutic Significance of Mesenchymal Stem Cells

Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response